Former senior executive at Becton Dickinson & Co.
- Diabetes device market overview, focusing on trends and themes within insulin management systems and pumps
- Competitive positioning of major players and comparative product analysis – Medtronic (NYSE: MDT), Becton Dickinson (NYSE: BDX), Insulet (NASDAQ: PODD) and Tandem (NASDAQ: TNDM)
- Technological developments and innovative capabilities to improve insulin delivery and management
- Outlook – type 2 diabetes penetration, US regulatory landscape and international opportunities
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.